Literature DB >> 28517022

Impact and management of left ventricular function on the prognosis of Takotsubo syndrome.

Ibrahim El-Battrawy1,2, Uzair Ansari1, Siegfried Lang1,2, Michael Behnes1, Katja Schramm1, Christian Fastner1, Xiaobo Zhou1,2, Jürgen Kuschyk1, Erol Tülümen1, Susanne Röger1, Martin Borggrefe1,2, Ibrahim Akin1,2.   

Abstract

BACKGROUND: Early research has proposed that patients with Takotsubo syndrome (TTS) could have a higher mortality rate than the general population. Our study was conducted to determine the short- and long-term outcome of TTS patients associated with a significantly compromised left ventricular function on hospital admission.
MATERIALS AND METHODS: Our institutional database constituted a collective of 112 patients diagnosed with TTS between 2003 and 2015. The patients were classified into two groups based on the left ventricular ejection fraction (LVEF), with those presenting with a LVEF > 35% on admission categorized into one group (n = 65, 58%) and those presenting with LVEF ≤ 35% (n=47, 42%) categorized into another group. The endpoint was the all-cause of mortality over a mean follow-up of 1529 ± 1121 days.
RESULTS: Preliminary results indicated that patients with an EF ≤ 35% had a significantly greater risk of developing life-threatening arrhythmias, and were much more likely to suffer from cardiogenic shock. Patients often required varying forms of mechanical respiratory support. The in-hospital mortality, 30-day mortality, 1-year mortality and ongoing long-term mortality was significantly higher in TTS patients with an EF ≤ 35%. In a multivariate Cox regression analysis, an EF ≤ 35% (HR 3·3, 95% CI: 1·2-9·2, P < 0·05) was identified as a strong independent predictor of the primary endpoint.
CONCLUSIONS: In-hospital events as well as short- and long-term mortality rates among TTS patients diagnosed with a significantly reduced LVEF on admission were significantly higher. There is an urgent need for randomized trials, which could help define uniform clinical management strategies for high risk TTS patients.
© 2017 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Devices; Takotsubo syndrome; echocardiography; ejection fraction; mortality; outcome

Mesh:

Year:  2017        PMID: 28517022     DOI: 10.1111/eci.12768

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Association Between Mortality and Left Ventricular Ejection Fraction in Patients With Takotsubo Syndrome Versus Acute Coronary Syndrome.

Authors:  Mohammad Abumayyaleh; Ibrahim El-Battrawy; Marvin Kummer; Thorsten Gietzen; Michael Behnes; Xiao-Bo Zhou; Siegfried Lang; Martin Borggrefe; Ibrahim Akin
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

2.  The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome.

Authors:  Marvin Kummer; Ibrahim El-Battrawy; Thorsten Gietzen; Uzair Ansari; Michael Behnes; Siegfried Lang; Xiaobo Zhou; Martin Borggrefe; Ibrahim Akin
Journal:  Front Pharmacol       Date:  2020-05-14       Impact factor: 5.810

3.  Short- and Long-Term Incidence of Thromboembolic Events in Takotsubo Syndrome as Compared With Acute Coronary Syndrome.

Authors:  Ibrahim El-Battrawy; Thorsten Gietzen; Siegfried Lang; Uzair Ansari; Michael Behnes; Xiaobo Zhou; Martin Borggrefe; Ibrahim Akin
Journal:  Angiology       Date:  2019-04-15       Impact factor: 3.619

4.  "Broken Heart" and "Broken Brain": Which Connection?

Authors:  Athanasios Papadis; Stefano Svab; Nicolas Brugger; Jonas Lanz; Robert von Arx; Konstantinos Stamou; Stefanos Sakellaropoulos
Journal:  Cardiol Res       Date:  2021-12-28

5.  Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy.

Authors:  Uzair Ansari; Ibrahim El-Battrawy; Christian Fastner; Michael Behnes; Katherine Sattler; Aydin Huseynov; Stefan Baumann; Erol Tülümen; Martin Borggrefe; Ibrahim Akin
Journal:  BMC Cardiovasc Disord       Date:  2018-03-20       Impact factor: 2.298

6.  Incidence, determinants and prognostic relevance of dyspnea at admission in patients with Takotsubo syndrome: results from the international multicenter GEIST registry.

Authors:  Luca Arcari; Maria Beatrice Musumeci; Thomas Stiermaier; Ibrahim El-Battrawy; Christian Möller; Federico Guerra; Giuseppina Novo; Enrica Mariano; Luca Rosario Limite; Luca Cacciotti; Raffaella Semeraro; Massimo Volpe; Francesco Romeo; Pasquale Caldarola; Holger Thiele; Ibrahim Akin; Natale Daniele Brunetti; Ingo Eitel; Francesco Santoro
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.